What is the most recent earnings date for PMVP stock?
PMV PHARMACEUTICALS INC (PMVP) last reported earnings on 3/6/2026.
NASDAQ:PMVP • US69353Y1038
Past quarterly earnings results for PMV PHARMACEUTICALS INC (PMVP), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.34 | -0.41 | 17.70% | 24.44% | - | - | ||
| Q3 2025 | -0.40 | -0.41 | 2.57% | -8.11% | - | - | ||
| Q2 2025 | -0.41 | -0.39 | -4.86% | -1,950.00% | - | - | ||
| Q1 2025 | -0.34 | -0.38 | 10.97% | -13.33% | - | - | ||
| Q4 2024 | -0.45 | -0.39 | -15.92% | -45.16% | - | - | ||
| Q3 2024 | -0.37 | -0.36 | -3.35% | -8.82% | - | - | ||
| Q2 2024 | -0.02 | -0.36 | 94.40% | 94.74% | - | - | ||
| Q1 2024 | -0.30 | -0.37 | 18.41% | 28.57% | - | - | ||
| Q4 2023 | -0.31 | -0.39 | 21.26% | 27.91% | - | - | ||
| Q3 2023 | -0.34 | -0.45 | 25.26% | 15.00% | - | - | ||
| Q2 2023 | -0.38 | -0.48 | 21.57% | - | - | - | ||
| Q1 2023 | -0.42 | -0.47 | 10.16% | -2.44% | - | - | ||
| Q4 2022 | -0.43 | -0.45 | 3.82% | -7.50% | - | - | ||
| Q3 2022 | -0.40 | -0.43 | 7.36% | -21.21% | - | - | ||
| Q2 2022 | -0.38 | -0.42 | 8.76% | -31.03% | - | - | ||
| Q1 2022 | -0.41 | -0.41 | 0.34% | -57.69% | - | - | ||
| Q4 2021 | -0.40 | -0.35 | -13.12% | 31.20% | - | - | ||
| Q3 2021 | -0.33 | -0.31 | -7.25% | 77.40% | - | - | ||
| Q2 2021 | -0.29 | -0.29 | -0.82% | - | - | - | ||
| Q1 2021 | -0.26 | -0.24 | -6.21% | - | - | - | ||
| Q4 2020 | -0.58 | - | - | - | - | |||
| Q3 2020 | -1.46 | -0.35 | -314.89% | - | - | - | ||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | - | - |
Notes
PMV PHARMACEUTICALS INC (PMVP) last reported earnings on 3/6/2026.
PMV PHARMACEUTICALS INC (PMVP) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, PMV PHARMACEUTICALS INC (PMVP) has beaten EPS estimates in 3 out of 4 releases.